Capital Growth Management LP Horizon Therapeutics Public LTD CO Transaction History

Capital Growth Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$67.0 - $84.39 $16.8 Million - $21.1 Million	-250,000 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$55.23 - $79.93 $16 Million - $23.2 Million	-290,000 Reduced 53.7%	250,000 $19.4 Million
Q2 2020 Aug 13, 2020	SELL	$30.2 - $56.98 $10.3 Million - $19.4 Million	-340,000 Reduced 38.64%	540,000 $30 Million
Q1 2020 May 15, 2020	BUY	$24.87 - $38.56 $870,450 - $1.35 Million	35,000 Added 4.14%	880,000 $26.1 Million
Q4 2019 Feb 13, 2020	BUY	$25.43 - $36.67 $21.5 Million - $31 Million	845,000 New	845,000 $30.6 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Capital Growth Management LP, based on Form 13F filings with the SEC.

Stay updated on Capital Growth Management LP with notifications on news.